AAAAAA

   
Results: 1-18 |
Results: 18
Overexpression of the p53 gene product in canine mammary tumors
Authors: Haga, S Nakayama, M Tatsumi, K Maeda, M Imai, S Umesako, S Yamamoto, H Hilgers, J Sarkar, NH
Citation: S. Haga et al., Overexpression of the p53 gene product in canine mammary tumors, ONCOL REP, 8(6), 2001, pp. 1215-1219
Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19 - Second report of the TD5 workshop
Authors: Nap, M van Wel, T Andres, C Bellanger, L Bodenmuller, H Bonfrer, H Brundell, J Einarsson, R Erlandsson, A Johansson, A Leca, JF Meier, T Seguin, P Sjodin, A Stigbrand, T Sundstrom, BE van Dalen, A Wiebelhaus, E Wiklund, B Hilgers, J
Citation: M. Nap et al., Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19 - Second report of the TD5 workshop, TUMOR BIOL, 22(1), 2001, pp. 4-10
T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer
Authors: Nijman, HW van Diest, PJ Poort-Keesom, RJJ von Mensdorff-Pouilly, S Verstraeten, RA Kummer, A Meijer, CJLM Melief, CJM Hilgers, J Kenemans, P
Citation: Hw. Nijman et al., T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer, EUR J OB GY, 94(1), 2001, pp. 114-120
Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients
Authors: Snijdewint, FGM von Mensdorff-Pouilly, S Karuntu-Wanamarta, AH Verstraeten, AA Livingston, PO Hilgers, J Kenemans, P
Citation: Fgm. Snijdewint et al., Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients, INT J CANC, 93(1), 2001, pp. 97-106
Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment
Authors: Paul, S Snary, D Hoebeke, J Allen, D Balloul, JM Bizouarne, N Dott, K Geist, M Hilgers, J Kieny, MP Burchell, J Papadimitriou, JT Acres, RB
Citation: S. Paul et al., Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment, HUM GENE TH, 11(10), 2000, pp. 1417-1428
Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1
Authors: Ryuko, K Schol, DJ Snijdewint, FGM von Mensdorff-Pouilly, S Poort-Keesom, RJJ Karuntu-Wanamarta, YA Verstraeten, RA Miyazaki, K Kenemans, P Hilgers, J
Citation: K. Ryuko et al., Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1, TUMOR BIOL, 21(4), 2000, pp. 197-210
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin
Authors: von Mensdorff-Pouilly, S Verstraeten, AA Kenemans, P Snijdewint, FGM Kok, A Van Kamp, GJ Paul, MA Van Diest, PJ Meijer, S Hilgers, J
Citation: S. Von Mensdorff-pouilly et al., Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin, J CL ONCOL, 18(3), 2000, pp. 574-583
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1peptides and N-acetylgalactosamine (GalNAc) peptides
Authors: von Mensdorff-Pouilly, S Petrakou, E Kenemans, P van Uffelen, K Verstraeten, AA Snijdewint, FGM van Kamp, GJ Schol, DJ Reis, CA Price, MR Livingston, PO Hilgers, J
Citation: S. Von Mensdorff-pouilly et al., Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1peptides and N-acetylgalactosamine (GalNAc) peptides, INT J CANC, 86(5), 2000, pp. 702-712
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma
Authors: Treon, SP Maimonis, P Bua, D Young, G Raje, N Mollick, J Chauhan, D Tai, YT Hideshima, T Shima, Y Hilgers, J von Mensdorff-Pouilly, S Belch, AR Pilarski, LM Anderson, KC
Citation: Sp. Treon et al., Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma, BLOOD, 96(9), 2000, pp. 3147-3153
Functional topography of discrete domains of human CD38
Authors: Ausiello, CM Urbani, F Lande, R la Sala, A Di Carlo, B Baj, G Surico, N Hilgers, J Deaglio, S Funaro, A Malavasi, F
Citation: Cm. Ausiello et al., Functional topography of discrete domains of human CD38, TISSUE ANTI, 56(6), 2000, pp. 539-547
Detection of humoral immune responses to mucins
Authors: von Mensdorff-Pouilly, S Vennegoor, C Hilgers, J
Citation: S. Von Mensdorff-pouilly et al., Detection of humoral immune responses to mucins, METH MOL B, 125, 2000, pp. 495-500
Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen
Authors: Stenman, UH Paus, E Allard, WJ Andersson, I Andres, C Barnett, TR Becker, C Belenky, A Bellanger, L Pellegrino, CM Bormer, OP Davis, G Dowell, B Grauer, LS Jette, DC Karlsson, B Kreutz, FT van der Kwast, TM Lauren, L Leinimaa, M Leinonen, J Lilja, H Linton, HJ Nap, M Nilsson, O Ng, PC Nustad, K Peter, A Pettersson, K Piironen, T Rapp, J Rittenhouse, HG Rye, PD Seguin, P Slota, J Sokoloff, RL Suresh, MR Very, DL Wang, TJ Wigheden, I Wolfert, RL Yeung, KK Zhang, WM Zhou, Z Hilgers, J
Citation: Uh. Stenman et al., Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen, TUMOR BIOL, 20, 1999, pp. 1-12
Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls
Authors: Snijdewint, FGM von Mensdorff-Pouilly, S Karuntu-Wanamarta, AH Verstraeten, AA van Zanten-Przybysz, I Hummel, P Nijman, HW Kenemans, P Hilgers, J
Citation: Fgm. Snijdewint et al., Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls, CANCER IMMU, 48(1), 1999, pp. 47-55
Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes byimmunomagnetic beads
Authors: Petrarca, C Casalino, B von Mensdorff-Pouilly, S Rughetti, A Rahimi, H Scambia, G Hilgers, J Frati, L Nuti, M
Citation: C. Petrarca et al., Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes byimmunomagnetic beads, CANCER IMMU, 47(5), 1999, pp. 272-277
Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer
Authors: Nijman, HW Kenemans, P Poort-Keesom, RJJ Verstraeten, RA Mensdorff-Pouilly, S Verheijen, RHM Melief, CJM Hilgers, J Meijer, CJLM
Citation: Hw. Nijman et al., Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer, EUR J OB GY, 83(2), 1999, pp. 201-206
Quantification of MUC1 in breast cancer patients - A method comparison study
Authors: Bon, GG van Kamp, GJ Verstraeten, RA von Mensdorff-Pouilly, S Hilgers, J Kenemans, P
Citation: Gg. Bon et al., Quantification of MUC1 in breast cancer patients - A method comparison study, EUR J OB GY, 83(1), 1999, pp. 67-75
Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma in situ of the breast
Authors: Mommers, ECM Leonhart, AM von Mensdorff-Pouilly, S Schol, DJ Hilgers, J Meijer, CJLM Baak, JPA van Diest, PJ
Citation: Ecm. Mommers et al., Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma in situ of the breast, INT J CANC, 84(5), 1999, pp. 466-469
Preclinical evaluation of two tumour associated antigens as potential immunogens for the immunotherapy of breast and ovarian cancer
Authors: Taylor-Papadimitrou, J Bodmer, W Melief, CJM Hilgers, J Real, FX Nuti, M Hanski, C
Citation: J. Taylor-papadimitrou et al., Preclinical evaluation of two tumour associated antigens as potential immunogens for the immunotherapy of breast and ovarian cancer, BIOM HLTH R, 24, 1998, pp. 107-111
Risultati: 1-18 |